Atara Biotherapeutics, Inc. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$3
Book Value Per Share
$-3
Free Cash Flow Per Share
$-4
Cash Per Share
$1
Revenue Per Share
$9
OCF Per Share
$-4
Return on Equity
-48.1%
Return on Assets
50.5%
Return on Invested Capital
-52.8%
Current Ratio
0.82
Quick Ratio
0.82
Asset Turnover
1.87
Days Sales Outstanding
3.79
R&D / Revenue
31.0%
SBC / Revenue
8.1%
Capex / Revenue
0.0%
Working Capital
$-3M
Net Current Asset Value
$-47M
Invested Capital
$-39M
OCF / Net Income
-1.56
FCF / Net Income
-1.56
Accruals Ratio (Sloan)
413.3%
Net Debt
$-8M
Net Debt / EBITDA
-0.22
Interest Coverage
9.46
Cash Coverage
-13.43
Capex Coverage
-279.34
Tangible Common Equity
$-39M
TCE / Total Assets
-190.3%
NOPAT
$36M
Cash ROIC
75.0%
WC / Revenue
-2.2%
Capex / D&A
0.00
Reinvestment Rate
-5.9%
Asset Growth vs Revenue Growth
-75.1%
Book Value 5Y CAGR
—
Stock Price (FY-end)
$18
Market Cap
$230M
P/E Ratio
7.04
P/S Ratio
1.90
P/B Ratio
—
P/TB Ratio
—
Enterprise Value
$222M
EV / EBITDA
5.83
EV / Sales
1.83
FCF Yield
-22.1%
Shareholder Yield
-4.2%
R&D Yield
16.3%
Capex Yield
0.0%
Shares Variation (YoY)
69.8%
Beta (5Y)
1.94
Cost of Equity
14.2%
52W High
$18
52W Low
$5
Trailing Return 1Y
48.9%
Trailing Return 5Y
-96.8%
F-Score (Piotroski)
4.00
Z-Score (Altman)
-125.88
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.